| |
| |
|
| Insider
Information: |
Bradsher Neal C |
| Relationship: |
10% Owner |
| City: |
Union City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
129,185 |
|
|
Indirect Shares
|
57,363,752 |
|
|
| Direct
Value |
$1,120,584 |
|
|
|
Indirect Value
|
$471,546,606 |
|
|
| Total
Shares |
57,492,937 |
|
|
| Total
Value |
$472,667,190 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
60
|
50
|
|
Stock
price went up :
|
44
|
16
|
| Stock
price went down : |
16
|
34
|
| |
|
|
|
Gain/Loss Ratio : |
2.8
|
2.8
|
| Percentage
Gain/Loss : |
 9.9%
|
 -929.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Questcor Pharmaceuticals Inc |
QCOR |
Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director, 10% Owner |
2024-02-06 |
87,628 |
2024-02-06 |
41,666,255 |
Premium* |
|
|
Comarco Inc |
CMRO |
10% Owner |
2017-09-15 |
15,500 |
2017-09-15 |
0 |
Premium* |
|
|
STAAR Surgical Co |
STAA |
10% Owner |
2024-05-09 |
25,900 |
2024-05-09 |
10,768,431 |
Premium* |
|
|
Palomar Medical Technologies Inc |
PMTI |
10% Owner |
2013-06-24 |
0 |
2013-06-24 |
0 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
See Remarks Below |
2019-03-08 |
0 |
2019-03-08 |
0 |
Premium* |
|
|
Oncocyte Corp |
OCX |
10% Owner |
2024-04-11 |
157 |
2024-04-11 |
4,929,066 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OCX |
Oncocyte Corp |
10% Owner |
– – • |
2023-04-03 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
50,181,335 |
1.42 |
% |
|
| OCX |
Oncocyte Corp |
10% Owner |
– – • |
2023-04-03 |
4 |
B |
$0.30 |
$8,093,898 |
D/D |
26,827,638 |
50,181,335 |
2.45 |
% |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2024-02-06 |
4 |
B |
$1.04 |
$7,000,001 |
D/D |
6,730,770 |
41,666,255 |
3.92 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2024-02-06 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
41,666,255 |
2.17 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2022-03-25 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
34,935,485 |
2.17 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2022-03-25 |
4 |
B |
$1.44 |
$678,022 |
D/D |
470,000 |
34,935,485 |
3.92 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2022-03-24 |
4 |
B |
$1.42 |
$284,340 |
D/D |
200,000 |
34,465,485 |
3.92 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2022-03-24 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
34,465,485 |
2.17 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2022-03-23 |
4 |
B |
$1.37 |
$355,305 |
D/D |
260,106 |
34,265,485 |
3.92 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2022-03-23 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
34,265,485 |
2.17 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2019-08-15 |
4 |
B |
$0.97 |
$12,717 |
D/D |
13,146 |
34,005,379 |
3.92 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2019-08-15 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
34,005,379 |
2.17 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2019-08-14 |
4 |
B |
$0.98 |
$1,379 |
D/D |
1,407 |
33,992,233 |
3.84 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2019-08-14 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
33,992,233 |
2.17 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2019-08-13 |
4 |
B |
$0.99 |
$9,949 |
D/D |
10,000 |
33,990,826 |
3.84 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2019-08-13 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
33,990,826 |
2.17 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2019-04-16 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
33,980,826 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2019-04-16 |
4 |
A |
$1.32 |
$332,397 |
D/D |
251,835 |
33,980,826 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2019-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,757,430 |
33,728,991 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2019-03-08 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
33,728,991 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2017-10-13 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
29,971,561 |
2.17 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2017-10-13 |
4 |
B |
$2.60 |
$6,999,998 |
D/D |
2,692,307 |
29,971,561 |
3.92 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2017-07-31 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
27,269,254 |
2.17 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2017-07-31 |
4 |
B |
$2.80 |
$420,000 |
D/D |
150,000 |
27,269,254 |
3.92 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • • |
2017-02-15 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
27,119,254 |
2.17 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
